NASDAQ: VERVVerve Therapeutics Inc Stock Ownership - Who owns Verve Therapeutics?
Insider buying vs selling
Have Verve Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sekar Kathiresan | Chief Executive Officer | 2025-04-02 | 9,822 | $4.15 | $40.76kSell |
| Jason Politi | Chief Technical Ops. Off. | 2025-04-02 | 3,235 | $4.15 | $13.43kSell |
| Allison Dorval | Chief Financial Officer | 2025-04-02 | 3,350 | $4.15 | $13.90kSell |
| Andrew D. Ashe | President Chief Operating Officer and General Counsel | 2025-04-02 | 2,681 | $4.15 | $11.13kSell |
| Troy Lister | Chief Scientific Officer | 2025-04-02 | 2,189 | $4.15 | $9.08kSell |
| Joan Nickerson | Chief Administrative Officer | 2025-04-02 | 2,777 | $4.15 | $11.52kSell |
| Allison Dorval | Chief Financial Officer | 2024-12-02 | 555 | $5.64 | $3.13kSell |
VERV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VERV insiders and whales buy or sell their stock.
VERV Shareholders
What type of owners hold Verve Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Alphabet Inc | 13.85% | 12,349,086 | $139.54M | Institution |
| Krishna Yeshwant | 13.65% | 12,168,489 | $137.50M | Insider |
| Gv 2017 GP LLC | 11.63% | 10,368,489 | $117.16M | Insider |
| Blackrock Inc | 8.84% | 7,878,236 | $89.02M | Institution |
| Bvf Inc | 7.74% | 6,904,050 | $78.02M | Institution |
| Gv 2019 GP LLC | 5.02% | 4,472,509 | $50.54M | Insider |
| Casdin Capital LLC | 4.48% | 3,995,571 | $45.15M | Institution |
| Vanguard Group Inc | 4.44% | 3,955,099 | $44.69M | Institution |
| State Street Corp | 3.47% | 3,091,189 | $34.93M | Institution |
| Novo Holdings A | 3.37% | 3,000,000 | $33.90M | Institution |
VERV vs Biotech Stocks
Verve Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.